Remarkably, MetaCore enrichment highlighted “Antigen presentation by MHC class I cross-presentation” as the top-ranked pathway, implicating ORMDL2 in dendritic cell-mediated cross-priming and tumor antigen evasion. This evidence concerns the gene ORMDL2 and neoplasm.